Bawa Pharmaceuticals Private Limited - Company Profile

It is a manufacturing private limited company based in New Delhi, Delhi, India, established in 1997.
1997 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Bawa Pharmaceuticals Private Limited

Bawa Pharmaceuticals Private Limited, a struck off private limited company, was established on 28 February 1997 in New Delhi, Delhi, India. Engaging in optical instruments such as binoculars within the manufacturing sector, it holds CIN: U33203DL1997PTC085484. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹11.21 Cr.

Its leadership includes Vikas Pawar (Director), Ravinder Lohia (Director). Past directors included Sitaram Singh. Its latest AGM occurred on 03 September 2012, with the balance sheet filed on 31 March 2012. It is based at 910 Ansal Bhawan 16, K. G. Marg, New Delhi, Delhi, 110001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33203DL1997PTC085484

  • Registration Number

    085484

  • Incorporation Date

    28 February 1997

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹11.21 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 11.21 Cr
  • Company Age 29 Year, 27 Days
  • Last Filing with ROC 31 Mar 2012
Company report

Bawa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bawa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Bawa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vikas Pawar Director 18 Sep 2000 Current
Ravinder Lohia Director 25 Mar 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 Mar 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bawa Pharmaceuticals.

Enhance accessibility to Bawa Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Bawa Pharmaceuticals revenue growth over time
Bawa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bawa Pharmaceuticals?

Unlock access to Bawa Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bawa Pharmaceuticals?

Unlock and access historical data on people associated with Bawa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bawa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bawa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bawa Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Ravinder Lohia was appointed as a Director was appointed as a Director on 25 Mar 2015 & has been associated with this company since 11 years 3 days . was completed.

  • Annual General Meeting

    Bawa Pharmaceuticals Private Limited last Annual general meeting of members was held on 03 Sep 2012 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Bawa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Vikas Pawar was appointed as a Director was appointed as a Director on 18 Sep 2000 & has been associated with this company since 25 years 6 months . was documented.

  • Company Incorporation

    Bawa Pharmaceuticals Private Limited was registered on 28 Feb 1997 with Roc Delhi & aged 29 years 27 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bawa Pharmaceuticals Private Limited?

The CIN of Bawa Pharmaceuticals Private Limited is U33203DL1997PTC085484.

Where is Bawa Pharmaceuticals Private Limited headquartered?

Bawa Pharmaceuticals Private Limited is headquartered at 910 Ansal Bhawan 16, K. G. Marg, New Delhi, Delhi, 110001.

When was Bawa Pharmaceuticals Private Limited incorporated?

Bawa Pharmaceuticals Private Limited was incorporated on 28 February 1997.

Who are the current directors of Bawa Pharmaceuticals Private Limited?

The current directors of Bawa Pharmaceuticals Private Limited are

What is the primary industry of Bawa Pharmaceuticals Private Limited?

The primary industry of Bawa Pharmaceuticals Private Limited is Manufacturing.

Is Bawa Pharmaceuticals Private Limited a listed company?

Bawa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bawa Pharmaceuticals Private Limited?

The authorized capital of Bawa Pharmaceuticals Private Limited is ₹12.00 Cr, and the paid-up capital is ₹11.21 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available